What is the prevalence of Relapsing Polychondritis?

Relapsing polychondritis is a rare, systemic inflammatory condition with an estimated prevalence of approximately 3.5 to 4.5 cases per million people. While exact global figures remain elusive due to underdiagnosis, the disease typically manifests in adulthood, with a peak incidence occurring between the ages of 40 and 60.

How common is Relapsing Polychondritis?

Relapsing polychondritis is classified as a rare disease. Because it is often misdiagnosed or overlooked in its early stages, reliable epidemiological data is difficult to obtain. Current estimates suggest an incidence rate of roughly 0.7 to 1 case per million people per year. Within the DiseaseMaps.org community, 468 individuals have connected to share their experiences, reflecting the global reach of this rare condition despite its low prevalence numbers.

Who is most affected by Relapsing Polychondritis?

Clinical observations indicate that relapsing polychondritis affects both genders with roughly equal frequency, though some literature suggests a slight female predominance in certain cohorts. Regarding the age of onset, while it can appear at any stage of life, it is most commonly diagnosed in middle-aged adults. Pediatric cases of relapsing polychondritis are documented but remain significantly rarer than adult-onset cases.

What factors influence prevalence data?

The primary challenges in determining the true prevalence of relapsing polychondritis include:

• Diagnostic Delay: The lack of specific diagnostic blood tests often leads to a long "diagnostic odyssey" for patients.


• Variable Presentation: Because relapsing polychondritis can affect diverse systems—from the respiratory tract to the circulatory system—patients may present to various specialists before reaching a rheumatologist.


• Under-reporting: Many mild cases may go undiagnosed or be misclassified as other forms of arthritis or inflammatory conditions.

Are there geographic or ethnic trends?

Current research has not identified a definitive geographic or ethnic "hotspot" for relapsing polychondritis. The disease appears to have a global distribution, affecting populations across diverse ethnic backgrounds with no clear predilection for specific regions or environmental exposures.

Next steps

• Consult with a board-certified rheumatologist to evaluate your specific symptoms.


• Connect with the 468+ members on DiseaseMaps.org to learn from the shared experiences of others living with relapsing polychondritis.


• Maintain a detailed symptom diary to assist your medical team in tracking disease activity and potential triggers.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Relapsing Polychondritis Overview.


• Orphanet: Relapsing Polychondritis (ORPHA:732).


• OMIM (Online Mendelian Inheritance in Man): Relapsing Polychondritis (Entry #266300).


• PubMed: Recent clinical reviews on the epidemiology and management of relapsing polychondritis.